Product NDC: | 67467-182 |
Proprietary Name: | Wilate - von Willebrand Factor/Coagulation Factor VIII Complex (Human) |
Non Proprietary Name: | von Willebrand Factor/Coagulation Factor VIII Complex (Human) |
Active Ingredient(s): | 1000; 1000 [iU]/10mL; [iU]/10mL & nbsp; von Willebrand Factor/Coagulation Factor VIII Complex (Human) |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 67467-182 |
Labeler Name: | Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. |
Product Type: | PLASMA DERIVATIVE |
FDA Application Number: | BLA125251 |
Marketing Category: | BLA |
Start Marketing Date: | 20091204 |
Package NDC: | 67467-182-01 |
Package Description: | 5 mL in 1 VIAL (67467-182-01) |
NDC Code | 67467-182-01 |
Proprietary Name | Wilate - von Willebrand Factor/Coagulation Factor VIII Complex (Human) |
Package Description | 5 mL in 1 VIAL (67467-182-01) |
Product NDC | 67467-182 |
Product Type Name | PLASMA DERIVATIVE |
Non Proprietary Name | von Willebrand Factor/Coagulation Factor VIII Complex (Human) |
Dosage Form Name | POWDER, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20091204 |
Marketing Category Name | BLA |
Labeler Name | Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. |
Substance Name | ANTIHEMOPHILIC FACTOR HUMAN; VON WILLEBRAND FACTOR HUMAN |
Strength Number | 1000; 1000 |
Strength Unit | [iU]/10mL; [iU]/10mL |
Pharmaceutical Classes | Human Antihemophilic Factor [EPC],Increased Coagulation Activity [PE],Blood Coagulation Factors [Chemical/Ingredient],Factor VIII [Chemical/Ingredient],Human Blood Coagulation Factor [EPC],Increased Platelet Aggregation [PE],Increased Coagulation Activity [PE],von Willebrand Factor [Chemical/Ingredient],Blood Coagulation Factors [Chemical/Ingredient] |